Analysis of Vaccine Antigens, Adjuvants, and Delivery Systems with Multi-Angle Light Scattering
Tuesday, March 4, 2025 9:30 AM to 12:00 PM · 2 hr. 30 min. (America/New_York)
Room 206B
Organized Session
Pharmaceutical & Biologics
Information
Vaccines play a critical role in the prevention of several diseases worldwide, and investment in vaccine development has increased on next generation technology and strategy. Vaccines have grown in complexity, sometimes requiring novel delivery systems and adjuvants. Based on this ever-growing complexity, analytical methods for analysis must adapt. In this session we will cover advancements in analytical strategy and methods for characterizing vaccine antigens, delivery systems (e.g. lipid nanoparticles), and adjuvants. The diversity in vaccines will be highlighted, including methods for characterizing new antigen strategies and next generation tools for gaining deeper understanding of existing products. The session will have a particular focus on analysis using multi-angle light scattering, which is an information rich detection method to understand macromolecules and particles. Principals covered in this session will be applicable to pharmaceuticals beyond vaccines, including antibody-drug conjugates and RNA therapeutics.
Day of Week
Tuesday
Session or Presentation
Session
Session Number
OC-02-00
Application
Pharmaceuticals
Methodology
Separation Sciences
Primary Focus
Application
Morning or Afternoon
Morning
Register
Register Now
Presentations
Light Scattering Solutions for Vaccine-Related Molecules and Nanoparticles
Tuesday, March 4, 2025 9:30 AM to 9:50 AM
Room 206B
Sophia Kenrick · Wyatt Technology, LLC
Leveraging Asymmetric-Flow Field-Flow Fractionation for Characterization of Stable Nanoemulsion Adjuvants
Tuesday, March 4, 2025 9:50 AM to 10:10 AM
Room 206B
Jack Terry · The University of Kansas
Asymmetrical Flow Field-flow Fractionation with Multi-angle Light Scattering for Separation and Characterization of Lipid Nanoparticles
Tuesday, March 4, 2025 10:10 AM to 10:30 AM
Room 206B
Juan Bian · Genentech
Enhancing the Utilization of MALS in the Vaccine R&D Environment
Tuesday, March 4, 2025 11:00 AM to 11:20 AM
Room 206B
Ray McClain · Merck
Real-time monitoring and control of downstream vaccine production processes by RT-MALS
Tuesday, March 4, 2025 11:20 AM to 11:40 AM
Room 206B
Daniel Some · Waters | Wyatt Technology